MycoBiomDB – Record Details (MyCo_5732)

Biomarker Record Details

Database ID: MyCo_5732
DB IDMyCo_5732
TitleDevelopment of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis
Year2018
PMID29712993
Fungal Diseases involvedMucormycosis
Associated Medical ConditionChronic lymphocytic leukemia
GenusCunninghamella
Speciesbertholletiae
OrganismCunninghamella bertholletiae
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker Name(FAM)TCGGTCGGCGTGGTTCTCTGCCCA (TAMRA)
Biomarker Full Name(FAM)TCGGTCGGCGTGGTTCTCTGCCCA (TAMRA)
Biomarker TypeDiagnostic
BiomoleculeGene
Geographical LocationFrance
CohortIn 2016, a 61-year-old man was diagnosed with stage-B chronic lymphocytic leukemia. He underwent a fourth chemotherapy cycle of rituximab, udarabine, and cyclo- sphosphamide (RFC) on 6th September (D0). On D21, he was admitted to the hematology unit for febrile aplasia. The fever persisted despite broad spectrum antibiotic therapy with piperacillin-tazobactam.
Cohort No.1
Age Group61
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismMucormycosis is a frequently fatal invasive mold infection that has emerged in immunocompromised patients. Classic risk factors for developing mucormycosis are diabetes, systemic or local steroid use, immunosuppressive therapy for solid organ or stem cell transplantation, neutropenia, and deferoxamine therapy. High doses of liposomal amphotericine B, posaconazole and surgery are the recommended therapeutic options. However, mucormycosis is still associated with high mortality rates, speci cally in hematological patients.
TechniquePCR
Analysis MethodqRT-PCR
ELISA kitsNone
Assay DataNone
Validation Techniques usedqRT-PCR
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone